GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Morepen Laboratories Ltd

Morepen Laboratories: Sushil Suri Re-appointed CMD for 3 Years

MANAGEMENT ▲ Positive Development LOW RISK
📅 Filed on BSE: 04 Aug 2026, 02:23 PM IST  ·  BSE ID: 7dae87d7-f0c9-4f67-83ab-ecdbff501c99
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved Sushil Suri's return as CMD and financial results, setting a date for dividend eligibility.
🤖 AI Summary
  • Mr. Sushil Suri re-appointed Chairman & Managing Director for 3 years from Oct 20, 2026.
  • Unaudited standalone & consolidated financial results for Q1 FY2027 approved.
  • Record date set for September 19, 2026, for final dividend of FY2026.
  • Extension of timeline for hiving off Medical Devices Business approved.
🔢 Key Numbers — exact figures from BSE filing, not rounded
CMD Re-appointment Period
3 years
CMD Re-appointment Effective Date
October 20, 2026
Quarterly Results Period
ended 30th June 2026
Dividend Record Date
Saturday, 19th September 2026
🏢 How This Affects the Company
📈
Business Impact
Re-appointment of CMD provides leadership continuity. Extension for business hiving-off impacts restructuring timeline.
💰
Financial Impact
Unaudited financial results for Q1 FY2027 provide current performance snapshot. Dividend declaration impacts retained earnings.
⚙️
Operational Impact
Hiving off Medical Devices Business into a subsidiary will alter operational structure.
⚠️
Risk Impact
Leadership continuity can reduce governance risk. Delays in business restructuring introduce execution risk.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding the CMD re-appointment or financial results disclosure.
👤
Who Is Affected
All shareholders are affected by the continuity in leadership and the proposed dividend eligibility.
🔍
Management Signal
The re-appointment signals management's intent to maintain established leadership and strategic direction.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Full FY2026 audited results announcement.
Progress on Medical Devices Business hiving-off.
Shareholder approval at 41st AGM.
LOW RISK Routine board decisions regarding leadership and financial reporting.
💡 Investor Takeaway
Morepen Laboratories confirmed Mr. Sushil Suri's re-appointment as CMD for three years from October 20, 2026, and approved Q1 FY2027 unaudited results.
❓ Frequently Asked Questions
Who has been re-appointed as Chairman & Managing Director of Morepen Laboratories?
Mr. Sushil Suri has been re-appointed as the Chairman & Managing Director of Morepen Laboratories.
For how long has Mr. Sushil Suri been re-appointed as CMD?
Mr. Sushil Suri has been re-appointed for a further period of three (3) years.
When is the re-appointment of Mr. Sushil Suri as CMD effective?
The re-appointment is effective from October 20, 2026, to October 19, 2029.
What financial results did Morepen Laboratories approve?
Morepen Laboratories approved the un-audited standalone & consolidated financial results for the quarter ended 30th June 2026.
What is the record date for Morepen Laboratories' final dividend for FY2026?
The record date is Saturday, September 19, 2026, for determining members eligible to receive the final dividend for FY2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.